End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.94 CNY | +0.65% | +10.90% | -25.73% |
04-26 | Shaanxi Kanghui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-15 | Kanghui Pharmaceutical to Earn 151 Million Yuan from Kelavi Buyback | MT |
Sales 2022 | 492M 67.89M 93.07M | Sales 2023 | 673M 92.96M 127M | Capitalization | 1.87B 259M 355M |
---|---|---|---|---|---|
Net income 2022 | -63M -8.7M -11.93M | Net income 2023 | -26M -3.59M -4.92M | EV / Sales 2022 | 4.24 x |
Net Debt 2022 | 313M 43.24M 59.28M | Net Debt 2023 | 318M 43.98M 60.3M | EV / Sales 2023 | 3.26 x |
P/E ratio 2022 |
-28.2
x | P/E ratio 2023 |
-72.2
x | Employees | 828 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.72% |
1 day | +0.65% | ||
1 week | +10.90% | ||
Current month | -8.95% | ||
1 month | -8.95% | ||
3 months | -15.52% | ||
6 months | -30.96% | ||
Current year | -25.73% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Ling Wang
CEO | Chief Executive Officer | 64 | 98-12-31 |
Bin Ze Zou
DFI | Director of Finance/CFO | 37 | 18-12-10 |
Jin Yang
BRD | Director/Board Member | 48 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Ping Hou
BRD | Director/Board Member | 63 | 09-12-10 |
Yan Ling Wang
CEO | Chief Executive Officer | 64 | 98-12-31 |
Jiang Hu
BRD | Director/Board Member | 60 | 19-12-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 13.94 | +0.65% | 1,445,100 |
24-04-29 | 13.85 | +3.67% | 1,692,500 |
24-04-26 | 13.36 | -0.37% | 1,436,800 |
24-04-25 | 13.41 | +1.82% | 1,381,900 |
24-04-24 | 13.17 | +1.31% | 1,517,078 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-25.73% | 192M | |
+20.61% | 43.18B | |
+20.67% | 22.59B | |
+14.56% | 14.56B | |
+13.94% | 13.54B | |
+43.35% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B |
- Stock Market
- Equities
- 603139 Stock